By: Luis Carlos Saiz, PharmD, Phd.
Innovation and Organization Unit, Navarre Health Service, Spain.
Among the explored options by the scientific community against the SARS-CoV-2 virus (COVID-19), drugs with antiviral activity stand out. This report assesses the scientific evidence shown by remdesivir (RDV) so far, in the context of the current pandemic.
Read the following information about medications compromising Covid infections below:
https://www.isdbweb.org/wp-content/uploads/Medications-Compromising-Covid-Infections-.pdf
COVID-19 and the quest for drugs and vaccines: Statement from the International Society of Drug Bulletins
The COVID-19 pandemic has called for all hands on deck worldwide. Evoking worst-case scenarios such as the Spanish flu of 1918, and the pandemic of the Mexican flu of 2009-2010, people are